CO21 Validation of Crossover Adjustment Outcomes in a Randomized Clinical Trial (RCT) Using Real-World Evidence (RWE) in Non-Small Cell Lung Cancer (NSCLC)

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.101
https://www.valueinhealthjournal.com/article/S1098-3015(22)02305-1/fulltext
Title : CO21 Validation of Crossover Adjustment Outcomes in a Randomized Clinical Trial (RCT) Using Real-World Evidence (RWE) in Non-Small Cell Lung Cancer (NSCLC)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02305-1&doi=10.1016/j.jval.2022.09.101
First page :
Section Title :
Open access? : No
Section Order : 10565
Categories :
Tags :
Regions :
ViH Article Tags :